Ataxia telangiectasia (A-T) is a rare genetic disorder characterized by progressive cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency, chromosomal instability, and radiation sensitivity (Peterson et al.
Introduction
Ataxia telangiectasia (A-T) is caused by mutations in the DNA damage response gene ataxia telangiectasia mutated (ATM) [1] located on chromosome 11 [2] . In response to the introduction of double-stranded DNA breaks, ATM normally halts the cell cycle to allow time for repair. ATM is also involved in mitogenic signal transduction, apoptosis, and interacts with numerous regulatory substrates including p53, BRCA1, CHK2, and Nbs1 [3] . A-T has a birth frequency of approximately one in 300,000 [4, 5] and up to 1% of the population are heterozygous carriers of mutated ATM genes [6] . Due to the pleiotropic effects of ATM, A-T patients may display clinical heterogeneity; however, the first signs of ataxia usually manifest by age 2 [7] [8] [9] . The characteristic telangiectasias may not appear until age 6 or later, and by their second decade, most patients require a wheelchair for mobility [7] [8] [9] . The degree of immunodeficiency is variable, with defects in humoral immunity, cellmediated immunity or both [10] . Classically, the most common findings include decreased serum IgA, IgG2 and IgG4, diminished numbers of naïve CD4 T cells, and thymic hypoplasia [10] . Other laboratory features typical of A-T include elevated alpha fetoprotein [11] , sensitivity to ionizing radiation and chromosomal breakage [12] . Up to 10% of the T-lymphocytes in A-T patients have translocations and inversions, mainly involving chromosomes 7 and 14, and some of these breakpoints are found within the T-cell antigen receptor genes on chromosome 7 [11] . A-T patients have an increased risk of developing cancer, and Hodgkin lymphoma accounts for 10% of all malignancies seen in these patients [13] . A-T patients present with Hodgkin lymphoma at a younger age than the general pediatric population, and usually at an advanced stage of disease [14] . The diagnosis of malignancy may precede the diagnosis of A-T or follow it.
Materials and methods

Histologic and immunophenotypic studies
Tissue from the bone marrow and lymph node biopsies was formalin fixed, paraffin embedded, and sectioned into hematoxylin and eosin-stained slides. Immunohistochemical studies were performed using the biotin-free Ultraview DAB detection system and an automated immunostainer (Ventana-Biotech, Tucson, AZ, USA). The following immunostains were performed using the following antibodies: anti-CD3 (Ventana, Tucson, AZ, USA), anti-CD15 (Becton Dickinson, San Jose, CA, USA), anti-CD20 (Ventana), anti-CD30 (Dako), fascin (Dako), and Pax 5 (clone 24 B-D Biosciences Lexington, KY, 1/50 dilution). Gomori methenaimine silver stain was used to identify yeast and fungal organisms in tissue. The Fite stain modification of the Ziehl-Neelsen stain was used to identify acid-fast organisms. Appropriate positive and negative controls were used for all immunohistochemical studies.
Molecular studies
In situ hybridization An automated in situ hybridization instrument was used to perform the in situ hybridization for Epstein-Barr virus (EBV). EBER-1, an EBV-encoded digoxigenin-labeled RNA riboprobe, was diluted in a 50% formamide-containing buffer and applied to the tissue sections and to appropriate positive and negative controls. An antisense riboprobe directed against a small nuclear ribonucleoprotein was used to confirm satisfactory RNA integrity of the tissue sections.
Results
Clinical history
The patient is a 6-year-old boy with a history of developmental delay and "clumsiness" who presented to the emergency room with abdominal pain, fever, and fatigue. On physical examination, he had hepatomegaly. Laboratory studies were notable for leukopenia (white blood cells 1.8 K/mm 3 ), anemia (hemoglobin 8.6 g/dl), elevated liver indices (115 IU/L, AST 74 IU/L, alkaline phostphatase 988 IU/L, total bilirubin 2.7 mg/dl), and a markedly elevated alpha fetoprotein (109.6 ng/ml). EBV serology revealed that the patient was positive for viral capsid antigen (VCA) IgG, but was negative for early antigen (EA), and Epstein-Barr nuclear antigen (EBNA). Acute lymphoblastic leukemia, viral hepatitis, hepatocellular carcinoma, and germ cell tumor were all considered in the differential diagnosis. The bone marrow biopsy revealed granulomas; however, an infectious etiology was ruled out. A computed tomography scan detected enlarged mediastinal, periaortic, and supraclavicular lymph nodes. While further bone marrow immunohistochemistry was pending, a subsequent lymph node biopsy with immunohistochemical analysis led to a diagnosis of stage IVB Hodgkin lymphoma, nodular sclerosis type. The diagnosis of Hodgkin lymphoma (HL) at this unusually young age prompted further clinical and laboratory work up which revealed oculomotor apraxia and subtle truncal ataxia as well as hypogammaglobulinemia (IgM 38 mg/dl, IgG2 47 mg/dl). Cytogenetic evaluation of the blood showed results consistent with ataxia telangiectasia (Fig. 3 ). Because A-T patients are exquisitely sensitive to radiation, the patient was put on a modified chemotherapeutic regimen developed at St. Jude's Hospital, which resulted in remission for 14 months; however, he relapsed and passed away by age9.
Bone marrow
Hematoxylin and eosin-stained sections from the bone marrow revealed non-necrotizing granulomas ( Fig. 1a) , eosinophilia, and rare large atypical cells with prominent eosinophilic nucleoli, suspicious for Reed-Sternberg cells ( Fig. 1b ). Fite and GMS stains of the bone marrow were negative for acid fast bacilli and fungal elements. Immunohistochemical staining showed that the large atypical cells in the bone marrow expressed CD30 ( Fig. 1c ) and weak PAX5, they were negative for CD20 and CD3. No definite staining for CD15 was observed, and a fascin stain was noncontributory.
Lymph node
A biopsy of the supraclavicular lymph node revealed architecture that was effaced by a mixed infiltrate of small lymphocytes, eosinophils, and scattered large abnormal cells; some sclerosis was present ( Fig. 2a ). The abnormal cells had large prominent hyperchromatic nucleoli ( Fig. 2b) , consistent with lacunar Reed-Sternberg variants. Rare classical Reed-Sternberg cells and mummified cells were also present ( Fig. 2c ). Immunohistochemical staining of the lymph node biopsy confirmed that the neoplastic cells expressed CD30 ( Fig. 2d ) and were negative for CD20 and CD3. A subset of Reed-Sternberg cells expressed CD15 in a Golgi distribution ( Fig. 2e ). This immunohistochemical pattern further supported the morphologic impression of classical Hodgkin lymphoma, nodular sclerosis type.
Molecular studies
Since Epstein-Barr virus is associated with lymphomas in immunodeficiency states, in situ hybridization for Epstein-Barr virus ribonucleic acid was performed and demonstrated numerous positive Reed-Sternberg cells in the lymph node ( Fig. 2f ) and occasional positive cells in the bone marrow ( Fig. 1d ).
Cytogenetic studies
Initial cytogenetic evaluations of the blood and lymph node were non-contributory due to poor growth in culture and low cell yield, respectively. Repeat cytogenetic analysis of the blood showed 10% of cells with chromosomal breakage, including three metaphases with 7;7 translocations, a 14;14 translocation, a 1;8 translocation and a dicentric chromosome (Fig. 3 ). The excess breakage in conjunction with the 7;7 and 14;14 translocations was characteristic of ataxia telangiectasia.
Discussion
Hematologic malignancy in A-T A-T patients have an increased risk of developing cancer, at approximately 100 times the age-specific population rate [5] . Of the A-T patients, 10-30% develop a malignancy and nearly 75% of these malignancies are lymphomas or leukemias [15] . Much of the data on the incidence of cancer subtypes in primary immunodeficiency patients comes from the National Immunodeficiency Cancer Registry (ICR) established in 1973 [16] .
A-T patients comprise approximately one third of the ICR; 21.3% of the total malignancies reported in ataxia telangiectasia were leukemias, 46% were lymphomas, and 10.7% were classified as Hodgkin lymphoma [13] .
Most cases of lymphoma in A-T occur in children and are diagnosed at a younger age than in the general pediatric population [11, 17] . Conversely, most cases of acute lymphoblastic leukemia in A-T present at an older age (average 9 years) [18] . Only one case of acute myeloid leukemia in an A-T patient has been reported in the [19] . Unlike the incidence of hematologic malignancies seen in other types of primary immunodeficiencies, there is a 6:1 ratio of T-cell to B-cell neoplasms in A-T, although the incidence of B-cell neoplasms is still increased compared to that of the general population [20] . In a UK case series examining leukemia and lymphoma subtypes in A-T patients, three of the 17 patients had B-cell tumors, at least 11 had T-cell tumors, and only patient had HL [20] . Only three of the patients were adults (ages 23-43 years); the remaining 14 were children aged 2-15, (median age 6) [20] . Young adults with A-T have an increased rate of T-PLL compared to children with A-T [20] . Of the non-Hodgkin B-cell lymphomas, diffuse large B-cell is reported with increased frequency relative to the other B-cell lymphomas [21, 22] .
Hodgkin lymphoma in A-T and a review of the literature
When comparing Hodgkin lymphoma in patients with ataxia telangiectasia to patients in the general population, notable differences involve the following: age at presentation, extent of disease involvement, histologic subtype, response to therapy and survival. A pediatric Hodgkin lymphoma case-control study comparing 20 HL cases (50% A-T, 45% immunoglobulin defects) from the ICR to 100 cases of HL in children without known immunodeficiency from the Late Effects Study Group confirmed that Hodgkin lymphoma occurs in A-T patients at a significantly younger age (mean 7.8 years) than in the general pediatric population (mean 11.5 years) [14] . In our literature review examining cases of HL in A-T (Table 1) , the average age at diagnosis was 9.6 years old (range 3-25, median 8.8 years). Often, diagnosed or suspected A-T patients present with recurrent sinopulmonary infections and are noted to have a lymphopenia which then leads to the diagnosis of malignancy. In some cases, as in our patient, the ataxia and telangiectasias may be subtle and the unusually young diagnosis of a particular malignancy leads to the search for a primary immunodeficiency.
All subtypes of HL have been reported in A-T; however, a review of the ICR shows that 42% of A-T patients show the mixed-cellularity subtype of HL and 33% of A-T patients have the lymphocyte depleted subtype [14] . These subtypes of HL are infrequently seen in developed countries, have an increased association with HIV, and are both highly associated with EBV [15] . Our patient's lymph node and bone marrow biopsies revealed nodular sclerosis HL, which is seen most often in the general population [15] , but is also the predominant subtype in another primary immunodeficiency, Wiskott-Aldrich syndrome [17] . Nodular sclerosis HL is less often associated with EBV, and is positive in only 10-40% of cases in the general population [15] . Table 1 shows a distribution of histologic subtypes similar to that of the ICR: 30% (11 of 37) lymphocyte depleted, 24% (nine of 37) mixed-cellularity, 13.5% (five of 37) nodular sclerosis, 30% (11 of 37) unspecified subtype, and one case which was classified as lymphocyte predominant HL.
A-T patients more often present with extranodal involvement and at an advanced stage [23] . In our review, 59% (16 of 27) cases were stage IV at diagnosis; and in instances where site of disease was specified, 50% (13 of 26) cases reviewed showed mediastinal involvement across all subtypes (Table 1 ). In contrast, mediastinal involvement is uncommon among the mixed-cellularity and lymphocytedepleted subtypes seen in the general population of HL patients [15] .
A-T patients with HL have significantly reduced survival compared to HL patients without immunodeficiency [24] , but it is somewhat challenging to make an honest comparison of HL treatment related to survival between the two groups. This is mainly due to the fact that standardized cohorts and retrospective studies examining the outcomes of HL in the general population are difficult to compare to individual case reports and decade-spanning case reviews that include varying degrees of detail and [25] , yet there is no clear evidence that reduced-dose chemotherapy is more appropriate for A-T [25] .
The role of EBV in malignancy and A-T
In 1981, an EBV genome-positive lymphoma was found in a mesenteric lymph node of a 9 year-old A-T patient [26] .
However, the role of EBV in A-T-associated lymphomas is unclear. One of the mechanisms that may be involved in EBV-associated lymphomas is the loss of immune surveillance, which can result in a derangement of the cytotoxic T-lymphocytes important in limiting the proliferation of EBV+cells. In the late 1970s, several studies of EBV in A-T patients reported an increased incidence of high antibody titers to VCA and EA. In conjunction with these findings, low to undetectable antibody titers to EBNA were noted, suggesting a deficiency of EBV-CTL activity [27, 28] . This pattern of high titers to VCA and Boder [16] n/a HD Axillary node/pharynx Lymphopenia N Dugois [31] 12/M HD/IVB Morgan [32] 9/M LP/IV Mediastinum Harris [33] 4/M MC Cervical node Y Frizzera [34] All <10 years MC LD×3 cases Bernstein [35] 25 EA with low to undetectable titers of EBNA is nonspecific and has been observed in autoimmune disease, EBVassociated malignancy and other types of immune dysfunction [29] . A study examining EBV titers in 60 A-T patients aged 3.5-20 years found that six of the patients went on to develop a hematolymphoid malignancy, and one of these six patients developed HL. The age at diagnosis, stage, histologic subtype and outcome were not reported, and the HL biopsy was not tested for the EBV genome [30] . EBV serology is not a dependable marker for malignancy in immunocompromised patients, and subsequent case reports on A-T patients with Hodgkin lymphoma have not examined tissue biopsies for the Epstein-Barr virus. To the best of our knowledge, this is the first known case of EBER-1 positive Hodgkin lymphoma in an ataxia-telangiectasia patient.
Conclusion
Notable features of this case included the unusually young age at presentation, advanced stage with bone marrow involvement at diagnosis and EBER positivity. Although the patient had a history of frequent sinopulmonary infections, a primary immunodeficiency was not diagnosed until the histologic diagnosis of Hodgkin lymphoma was made on the bone marrow and mediastinal lymph node. The elevated alpha-fetoprotein, decreased IgG2 and IgA, and most importantly, the confirmatory chromosomal breakage with 7;7 and 14;14 translocations further supported the diagnosis of ataxia-telangiectasia. This case highlights the importance of evaluating young children with advanced stage Hodgkin lymphoma for the presence of primary immunodeficiency.
